Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 1, 2000
April 21, 2020
8a3da1bc-1ebb-48aa-a3ea-7662562c4370
Related Documents
Repeal of Section 507 of the Federal Food, Drug and Cosmetic Act _1
Guidance DocumentJune 15, 1998Center for Drug Evaluation and Research
Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations
Guidance DocumentSeptember 1, 1997Center for Drug Evaluation and Research
Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies
Guidance DocumentDecember 11, 2001Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.